The First Peptidic T-type Ca2+-Channel Blocker
Voltage-dependent Ca2+-channels are classified according to the nature of their a1 subunits. High
voltage-activated channels (HVA) are composed of a1A-a1F/a1S, leading to L-, N-, P/Q- and R-type
channels. Peptidic blockers specific for each channel are commercially available List of Ion Channel Blockers. Low voltage-activated channels (LVA) are encoded by a1G-a1I,
which correspond to T-type channels. Although these channels are known to be blocked by Ni2+ ions,
until recently there was no peptidic blocker for this particular channel.
Kurtoxin:
Lys-Ile-Asp-Gly-Tyr-Pro-Val-Asp-Tyr-Trp-Asn-Cys-Lys-Arg-Ile-Cys-Trp-Tyr-Asn-Asn-
Lys-Tyr-Cys-Asn-Asp-Leu-Cys-Lys-Gly-Leu-Lys-Ala-Asp-Ser-Gly-Tyr-Cys-Trp-Gly-Trp-
Thr-Leu-Ser-Cys-Tyr-Cys-Gln-Gly-Leu-Pro-Asp-Asn-Ala-Arg-Ile-Lys-Arg-Ser-Gly-Arg-
Cys-Arg-Ala
However, in 1998, a new T-type channel blocker, kurtoxin, was isolated from the venom of the
South African scorpion (Parabuthus transvaalicus). This compound is a 63 amino acid residue
peptide with 4 intramolecular disulfide linkages[Nat. Neurosci., 1, 668 (1998) ]. Using the expressed a1G channel, the binding of
kurtoxin was found to involve 1:1 stoichiometry with a Kd value of 15 nM. Almost complete
inhibition by kurtoxin was observed for the a1G channel at 350 nM, whereas the a1H channel was
blocked approximately 85% at the same concentration. a1A- a1C and a1E Channels were not affected at
350 nM, indicating the specific blocking activity of kurtoxin for the expressed T-type channels.
Because of the sequence similarity with a-scorpion toxins, kurtoxin binds to voltage-gated Na+
channels and slows their inactivation. Later, it was clarified that this peptide interacts with both HVA
and LVA channels in rat central and peripheral neurons: i) N- and L-type channel currents were
partially inhibited by 250-500 nM peptide (Kd=456 nM and 72 nM, respectively), ii) P-type Ba2+
current in Purkinje neurons was facilitated by 500 nM peptide (Kd=14 nM), and iii) Kd for thalamic
T-type channels was 49 nM[J. Neurosci., 22, 2023 (2002) ]. The reason for this discrepancy between two reports remains to be
clarified, however. T-type channel blocking activity of kurtoxin is attractive because this peptide does
interact with both expressed and native T-type channels.
Kurtoxin is a useful blocker for T-type channels, especially when used in combination with the
various blockers for HVA channels for further research investigations.
| Code | Compound | Package | Price(Yen) |
| 4375-s | Kurtoxin | 0.1 mg vial | 30,000 |
| Code | Compound | Selectivity | Package | Price(Yen) |
| 4255-s | Calciseptine | L-type Blocker | 0.1 mg vial | 30,000 |
| 4310-s | Calcicludine | L-type Blocker | 0.1 mg vial | 30,000 |
| 4161-v | w-Conotoxin GVIA | N-type Blocker | 0.5 mg vial | 38,000 |
| 4289-v | w-Conotoxin MVIIA | N-type Blocker | 0.5 mg vial | 30,000 |
| 4284-v | w-Conotoxin SVIB | N-type Blocker | 0.5 mg vial | 30,000 |
| 4256-s | w-Agatoxin IVA | P-type Blocker | 0.1 mg vial | 30,000 |
| 4294-s | w-Agatoxin TK | P-type Blocker | 0.1 mg vial | 30,000 |
| 4283-s | w-Conotoxin MVIIC | P/Q-type Blocker | 0.1 mg vial | 15,000 |
| 4363-s | SNX-482 | R-type Blocker | 0.1 mg vial | 30,000 |